Stocktwits on MSN
Eli Lilly Stock Jumps Premarket On Dumping CVS Drug Plan After Wegovy Snub — Retail Calls It A Pushback Against PBM Power
Lilly is reportedly shifting its 50,000 employees to Rightway, a fintech-driven pharmacy benefit manager, starting January 1.
KEF MediaCommunity pharmacies have become a cornerstone of local health care, offering much more than prescriptions. From vaccinations to wellness checks, pharmacists are stepping up ...
ARS Pharmaceuticals, Inc. ( SPRY) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Good morning and welcome to ARS Pharmaceuticals Conference Call. [Operator Instructions] Please be advised that ...
Q3 2025 Earnings Call Transcript October 29, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.6, ...
North Carolina's State Health Plan can negotiate directly with the manufacturers of GLP-1 medications under a new agreement with CVS Caremark, its pharmacy benefit manager. That agreement represents ...
Capitol Weekly welcomes Opinions on California public policy or politics. Click here for more information about submitting an Op-Ed. OPINION – For my family, pharmacy is more than a profession—it’s a ...
Gov. Kathy Hochul on Tuesday said she would extend an executive order letting pharmacists prescribe and administer COVID-19 vaccines to any New Yorker who requests one when it expires in a few weeks.
Oklahoma Attorney General Gentner Drummond says he’s reached a $32.1 million settlement with pharmacy benefit manager CVS Caremark after he alleged the company kept money that belonged to HealthChoice ...
A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...
A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager ...
Caremark is ordered to pay $289.9 million for inflated drug claims, impacting Medicare Part D payments. The ruling highlights ongoing legal challenges in the pharmaceutical industry, including Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results